Henderson Jane Insider Trading Activity
Henderson Jane has been net-selling over the last 12 months with 0 purchases and 22 sales across 2 different companies.
APGE is the most-traded position with 21 trades. The largest single transaction was a sale of APGE for $307K on Jan 2, 2026.
Performance Scorecard
Forward stock performance after each transaction by Henderson Jane. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -3.0% | 45% | 22 |
| 90 days | — | -19.7% | 16% | 19 |
| 120 days | — | -32.3% | 0% | 15 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Henderson Jane bought and sold APGE.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 1, 2026 | APGE | Sell | 900 | $82.60 | $74K | −0.5% | CFO | |
May 1, 2026 | APGE | Sell | 811 | $81.02 | $66K | −0.5% | CFO | |
May 1, 2026 | APGE | Sell | 289 | $83.16 | $24K | −0.2% | CFO | |
Apr 16, 2026 | APGE | Sell | 2,000 | $90.00 | $180K | −1.1% | CFO | |
Apr 1, 2026 | APGE | Sell | 900 | $84.46 | $76K | −0.5% | CFO | |
Apr 1, 2026 | APGE | Sell | 1,100 | $85.46 | $94K | −0.6% | CFO | |
Mar 25, 2026 | APGE | Sell | 2,000 | $85.00 | $170K | −1.1% | CFO | |
Mar 2, 2026 | APGE | Sell | 300 | $68.27 | $20K | −0.2% | CFO | |
Mar 2, 2026 | APGE | Sell | 994 | $70.45 | $70K | −0.5% | CFO | |
Mar 2, 2026 | APGE | Sell | 406 | $71.66 | $29K | −0.2% | CFO | |
Feb 2, 2026 | APGE | Sell | 1,108 | $66.15 | $73K | −0.6% | CFO | |
Feb 2, 2026 | APGE | Sell | 792 | $65.21 | $52K | −0.4% | CFO | |
Feb 2, 2026 | APGE | Sell | 100 | $66.89 | $7K | −0.1% | CFO | |
Jan 6, 2026 | APGE | Sell | 2,000 | $80.00 | $160K | −1.1% | CFO | |
Jan 2, 2026 | APGE | Sell | 1,920 | $74.13 | $142K | −1.0% | CFO | |
Jan 2, 2026 | APGE | Sell | 4,080 | $75.20 | $307K | −2.1% | CFO | |
Dec 19, 2025 | APGE | Sell | 1,500 | $80.00 | $120K | −0.8% | CFO | |
Dec 4, 2025 | APGE | Sell | 1,500 | $75.00 | $113K | −0.8% | CFO | |
Nov 25, 2025 Filed 3d late | APGE | Sell | 1,500 | $70.00 | $105K | −0.8% | CFO | |
Nov 14, 2025 | APGE | Sell | 2,000 | $65.00 | $130K | −1.0% | CFO | |
Nov 11, 2025 | APGE | Sell | 1,000 | $60.00 | $60K | −0.5% | CFO | |
Aug 12, 2025 | AKRO | Sell | 3,000 | $47.46 | $142K | −24.2% | Director |
Top Companies Traded
Other insiders at Apogee Therapeutics, Inc.
2 other tracked filers at APGE.